Syndicate content Barron's Features
Barron's Features
Updated: 1 year 19 weeks ago

A Tribute to Jack Bogle

Thu, 02/28/2019 - 01:38
The inventor of the index fund and founder of Vanguard Group made investing possible for ordinary Americans

Office REITs at Bargain Prices

Thu, 02/28/2019 - 01:08
Real estate investment trusts that specialize in office properties have badly lagged the overall REIT market. But be careful: Not every region is equally attractive.

Which Online Broker Best Suits Your Needs?

Tue, 02/26/2019 - 04:20
Barron’s released its annual ranking of the best online brokers of 2019. Here’s a look at how the brokers stack up on the categories of mobile, international, retirement, active and occasional.

Snapshots From Barron's 2019 Top Online Brokers

Tue, 02/26/2019 - 04:17
Barron’s published its annual ranking of the top online brokers for 2019. Here’s a look at some of the top performers.

WellCare Poised to Ride Surging Medicare and Medicaid Spending

Tue, 02/26/2019 - 00:17
The Medicare and Medicaid plan manager has been hurt by overblown worries about its swift growth and earnings outlook, plus uncertainty over Obamacare’s future.

Star Stockpicker Exits the Hedge Fund Stage

Mon, 02/25/2019 - 22:39
Steve Mandel has quietly given up the reins at Lone Pine Capital after two decades of market-beating returns

ECB's Coeuré on the Risks of Political Jitters to Growth

Mon, 02/25/2019 - 22:21
‘It’s always a mistake to underestimate the strength of the European project,’

How We Ranked the 2019 Best Online Brokers

Sat, 02/23/2019 - 08:15
Barron’s released its 2019 ranking of the 2019 best online brokers. Here’s how the rankings were determined.

Loews: A Conglomerate That Investors Can Love

Fri, 02/22/2019 - 00:24
The value-focused, family-controlled company has underappreciated assets with decent growth prospects.

5 Smart Plays on the Robotics Revolution

Thu, 02/21/2019 - 23:20
New technologies are making robotic automation more versatile and more accessible. It’s time to invest in Teradyne, ABB, and other robot makers

4 Stocks to Play the Data-Center Boom

Thu, 02/21/2019 - 23:19
Equinix, CoreSite Realty, Iron Mountain, and Interxion look alluring as companies increasingly tap into the cloud for software and data storage.

U.S. Marijuana Sellers On a Tortuous Path to Widespread Approval

Thu, 02/21/2019 - 21:40
Cannabis companies like Curaleaf and Acreage can’t list their stocks in the U.S., or draw on U.S. bank lines. They also must cope with wide variations in state regulations. Don’t look for much progress from the federal government for at least a year.

Stocks to Buy in China's Slowing Economy

Tue, 02/19/2019 - 23:29
Sophisticated investors are putting money into innovators and consumer stocks that ultimately will benefit from Beijing’s new economic plans.

Methodology: How Calvert Research and Management Produced the Barron's Ranking

Tue, 02/12/2019 - 21:41
Here’s how Calvert ranked the companies

The 20 Most Sustainable International Companies

Tue, 02/12/2019 - 02:57
Barron’s asked Calvert Research and Management to rank the 20 most sustainable non-U.S. firms. The list is mostly European and, on average, a more forward-looking group than the U.S. companies.

Time to Board the Wabtec Special

Sat, 02/09/2019 - 08:14
The railroad-equipment maker’s battered shares look alluring, despite worries about the merger with GE Transportation

BB&T and SunTrust: Buy the Deal but Don't Fall for the Trend

Sat, 02/09/2019 - 07:18
The biggest bank deal since the financial crisis has raised hopes that it could spark a new frenzy of banking mergers. Yet there are reasons to think this deal could prove to be a one-off.

Bill Gross Made the Bond Market What It Is Today

Sat, 02/09/2019 - 06:09
Despite a disappointing recent performance at Janus, Gross deserves his place in the pantheon of pioneering giants of modern markets.

A Stock at the Center of a Fierce Psychiatric Debate

Sat, 02/09/2019 - 05:56
Myriad Genetics’ new product aims to steer doctors to the right antidepressant for patients. But some researchers question its effectiveness, particularly in light of its high price and possible conflicts of interest. The outcome could send the shares sharply higher or lower.

Eli Lilly to Unload Remaining Elanco Stock

Fri, 02/08/2019 - 21:50
The drug giant announced on Friday that it will unload the remaining shares it holds of Elanco Animal Health through a voluntary stock-exchange offer.